UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Journal of clinical oncology, 2016-10, Vol.34 (28), p.3400-3408

2016

Volltextzugriff (PDF)

The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3565-3571

2013

Volltextzugriff (PDF)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

British journal of cancer, 2016-04, Vol.114 (9), p.956-964

2016

Volltextzugriff (PDF)

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

The lancet oncology, 2023-04, Vol.24 (4), p.323-334

2023

Volltextzugriff (PDF)

Hypersensitivity reaction (HSR) to docetaxel after a previous HSR to paclitaxel

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2760-2761

2002

Volltextzugriff (PDF)

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Annals of oncology, 2015-11, Vol.26 (11), p.2280-2286

2015

Volltextzugriff (PDF)

Describing Patterns of Care in Pancreatic Cancer: A Population-Based Study

Pancreas, 2015-11, Vol.44 (8), p.1259-1265

2015

Volltextzugriff (PDF)

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

British journal of cancer, 2012-01, Vol.106 (1), p.61-69

2012

Volltextzugriff (PDF)

Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.12019-12019

2023

Volltextzugriff (PDF)

PEARL: A randomised phase 3 trial of palliative care early in advanced lung cancers (ALTG/TOGA 13/008)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12020-12020

2022

Volltextzugriff (PDF)

Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.12008-12008

2020

Volltextzugriff (PDF)

Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9534-9534

2019

Volltextzugriff (PDF)

Low-dose oral cyclophosphamide-methotrexate maintenance (CMM) for receptor-negative early breast cancer (BC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1002-1002

2015

Volltextzugriff (PDF)

Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis [corrected]

European journal of cancer (1990), 2011-08, Vol.47 (12), p.1826-1836

2011

Volltextzugriff (PDF)

Abstract P1-12-06: Co-SOFT: The cognitive function substudy of the suppression of ovarian function trial (SOFT)

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P1-P1-12-06

2015

Volltextzugriff (PDF)

Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.228-228

2014

Volltextzugriff (PDF)

Usefulness of medical oncologists’ estimates of survival time in people with advanced cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.9087-9087

2012

Volltextzugriff (PDF)

Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15152-e15152

2012

Volltextzugriff (PDF)

Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.211-211

2012

Volltextzugriff (PDF)

Adjuvant chemoimmuno- and immunotherapy in Dukes' stage B2 and C colorectal carcinoma: A 7-year follow-up analysis

Journal of surgical oncology, 1989-03, Vol.40 (3), p.205-213

1989

Volltextzugriff (PDF)

Pulmonary Sarcoidosis Following Interferon Therapy for Advanced Renal Cell Carcinoma

Cancer, 1987-03, Vol.59 (5), p.896-900

1987

Volltextzugriff (PDF)

An unusual case of renal cancer showing mixed tumor response to interferon

The American journal of medicine, 1987-12, Vol.83 (6), p.1147-1150

1987

Volltextzugriff (PDF)

Adjuvant chemoimmuno‐ and immunotherapy in Dukes' stage B 2 and C colorectal carcinoma: A 7‐year follow‐up analysis

Journal of surgical oncology, 1989-03, Vol.40 (3), p.205-213

1989

Volltextzugriff (PDF)

Combination of interferon and prednisone in human cancer

European journal of cancer & clinical oncology, 1988-04, Vol.24 (4), p.723-724

Abdi, Ehtesham A.

1988

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Hypersensitivity reaction (HSR) to docetaxel after a previous HSR to paclitaxel

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Describing Patterns of Care in Pancreatic Cancer: A Population-Based Study

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial

PEARL: A randomised phase 3 trial of palliative care early in advanced lung cancers (ALTG/TOGA 13/008)

Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV)

Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Low-dose oral cyclophosphamide-methotrexate maintenance (CMM) for receptor-negative early breast cancer (BC)

Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis [corrected]

Abstract P1-12-06: Co-SOFT: The cognitive function substudy of the suppression of ovarian function trial (SOFT)

Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study

Usefulness of medical oncologists’ estimates of survival time in people with advanced cancer

Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial

Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial

Adjuvant chemoimmuno- and immunotherapy in Dukes' stage B2 and C colorectal carcinoma: A 7-year follow-up analysis

Pulmonary Sarcoidosis Following Interferon Therapy for Advanced Renal Cell Carcinoma

An unusual case of renal cancer showing mixed tumor response to interferon

Adjuvant chemoimmuno‐ and immunotherapy in Dukes' stage B 2 and C colorectal carcinoma: A 7‐year follow‐up analysis

Combination of interferon and prednisone in human cancer

Suchergebnisse filtern